You are here

Article info

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia

Authors

  • Jens Bauer Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Regina Bohnert Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany PubMed articlesGoogle scholar articles
  • Elke Schaeffeler Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany PubMed articlesGoogle scholar articles
  • Jonas Scheid Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Marissa Dubbelaar Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Annika Nelde Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Marcel Wacker Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany University and University Hospital Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Hans-Georg Rammensee Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Matthias Schwab Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles
  • Juliane S Walz Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany Cluster of Excellence iFIT (EXC2180) ‘Image-Guided and Functionally Instructed Tumor Therapies’, University of Tübingen, Tübingen, Germany Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany PubMed articlesGoogle scholar articles

Citation

Bauer J, Bohnert R, Schaeffeler E, et al
872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0872
Online issue publication 
November 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.